XML 54 R39.htm IDEA: XBRL DOCUMENT v3.3.1.900
Consolidation of Variable Interest Entity - Pro Forma Financial Information (Unaudited) (Detail) - USD ($)
 12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Schedule Of Equity Method Investments [Line Items]    
Net loss in equity investments $ (2,445,489) $ (910,200)
Milestone Medical Inc. [Member]    
Schedule Of Equity Method Investments [Line Items]    
Revenue 9,542,544 10,333,089
Cost of sales 3,061,299 3,630,765
Gross profit 6,481,245 6,702,324
Selling, general and administrative expenses 12,645,445 8,899,447
Research and development expenses 892,255 489,551
Total operating expenses 13,537,700 9,388,998
Loss income from operations (7,056,455) (2,686,674)
Other Expenses (5,347)  
Interest Expense (40,331) (2,955)
Interest Income 3,838 5,057
Loss before provision for income taxes (7,098,295) (2,684,572)
Provision for income tax (36,157) (9,509)
Loss before equity in net earnings of equity investments (7,134,452) (2,694,081)
Net loss in equity investments (2,019,211) (891,500)
Net loss in equity investments (426,278) (18,700)
Net loss (7,560,730) (2,712,781)
Net loss attributable to the noncontrolling interests 2,093,208 954,423
Net loss attributable to Milestone Scientific Inc. (5,467,522) (1,758,358)
Milestone Education LLC [Member]    
Schedule Of Equity Method Investments [Line Items]    
Net loss in equity investments (7,846) (17,890)
Milestone China [Member]    
Schedule Of Equity Method Investments [Line Items]    
Net loss in equity investments (348,651) (810)
Loss on earnings from China Joint Venture $ (418,432) $ (810)